Treace Medical Concepts Inc (TMCI) — Cash Flow Reinvestment Rate
Latest as of March 2026:
0.42x
Treace Medical Concepts Inc (TMCI) has a Cash Flow Reinvestment Rate of 0.42x as of March 2026, reinvesting $3.06 Million (capex $3.06 Million ) from operating cash flow of $7.24 Million. Explore TMCI capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.42x
(Capex + Investments) / Operating CF
Total Reinvested
$3.06 Million
Capex + Investments
Operating Cash Flow
$7.24 Million
USD
Capital Expenditures
$3.06 Million
USD
Annual Cash Flow Reinvestment Rate for Treace Medical Concepts Inc (None–None)
Year-by-year capital reinvestment analysis for Treace Medical Concepts Inc. For live market cap and broader valuation context, see Treace Medical Concepts Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow